XML 113 R85.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Non-Controlling Interest (Details) - USD ($) | Dec. 31, 2023 | Feb. 01, 2023 | Dec. 31, 2022 | Feb. 25, 2022 | Dec. 31, 2021 | Dec. 30, 2021 | Jan. 02, 2021
--- | --- | --- | --- | --- | --- | --- | ---
Non-Controlling Interest [Line Items] |  |  |  |  |  |  |
Share issued (in Shares) |  | 122 |  | 119 |  | 0.001 | 117
Total deficit value (in Dollars) | $ 67,766 |  | $ 52,024 |  | $ 34,130 |  |
Mios Pharmaceuticals Limited [Member] |  |  |  |  |  |  |
Non-Controlling Interest [Line Items] |  |  |  |  |  |  |
Ownership interest percentage | 97.93% |  |  |  |  |  |
Total deficit value (in Dollars) |  |  |  |  | $ 27,293 |  |
Scipio Life Sciences Limited [Member] |  |  |  |  |  |  |
Non-Controlling Interest [Line Items] |  |  |  |  |  |  |
Ownership interest percentage | 97.93% |  |  |  |  |  |
Aptorum Medical Limited [Member] | Maximum [Member] |  |  |  |  |  |  |
Non-Controlling Interest [Line Items] |  |  |  |  |  |  |
Equity interest percentage |  |  |  |  |  |  | 93.00%
Aptorum Medical Limited [Member] | Minimum [Member] |  |  |  |  |  |  |
Non-Controlling Interest [Line Items] |  |  |  |  |  |  |
Equity interest percentage |  |  |  |  |  |  | 92.00%
Clark Cheng [Member] | Maximum [Member] |  |  |  |  |  |  |
Non-Controlling Interest [Line Items] |  |  |  |  |  |  |
Equity interest percentage |  | 91.00% |  | 92.00% |  |  |
Clark Cheng [Member] | Minimum [Member] |  |  |  |  |  |  |
Non-Controlling Interest [Line Items] |  |  |  |  |  |  |
Equity interest percentage |  | 90.00% |  | 91.00% |  |  |
Group’s subsidiaries [Member] | Mios Pharmaceuticals Limited [Member] |  |  |  |  |  |  |
Non-Controlling Interest [Line Items] |  |  |  |  |  |  |
Voting power | 36.17% |  |  |  |  |  |
Group’s subsidiaries [Member] | Scipio Life Sciences Limited [Member] |  |  |  |  |  |  |
Non-Controlling Interest [Line Items] |  |  |  |  |  |  |
Voting power | 35.06% |  |  |  |  |  |

X
- Definition Amount of fresh-start adjustment to retained earnings or deficit. + References No definition available. + Details
Name: | apm_AdjustmentIncreaseDecreaseRetainedEarningsDeficit
Namespace Prefix: | apm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References No definition available. + Details
Name: | apm_NonControllingInterestLineItems
Namespace Prefix: | apm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2 + Details
Name: | us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of units of other ownership interests issued in a limited partnership or master limited partnership. Does not include limited or general partners' ownership interests. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 5 -Subparagraph (SAB TOPIC 4.F) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-5 + Details
Name: | us-gaap_OtherOwnershipInterestsUnitsIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total of all Partners' Capital (deficit) items which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(22)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 5 -Subparagraph (SAB Topic 5.F) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-5 + Details
Name: | us-gaap_PartnersCapitalAttributableToNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | srt_OwnershipAxis=apm_MiosPharmaceuticalsLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_ScipioLifeSciencesLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=apm_AptorumMedicalLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=apm_ClarkChengMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=apm_GroupsSubsidiariesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |